Literature DB >> 25164554

IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer.

.   

Abstract

Entities:  

Year:  2014        PMID： 25164554     DOI： 10.1038/onc.2014.224

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


× No keyword cloud information.
  3 in total

1.  TUGDA: task uncertainty guided domain adaptation for robust generalization of cancer drug response prediction from in vitro to in vivo settings.

Authors:  Rafael Peres da Silva; Chayaporn Suphavilai; Niranjan Nagarajan
Journal:  Bioinformatics       Date:  2021-05-17       Impact factor: 6.937

Review 2.  Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.

Authors:  Pei-Yu Chen; Wen-Fei Wei; Hong-Zhen Wu; Liang-Sheng Fan; Wei Wang
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

3.  Targeting Interleukin-6 (IL-6) Sensitizes Anti-PD-L1 Treatment in a Colorectal Cancer Preclinical Model.

Authors:  Jibin Li; Jian Xu; Xiaofei Yan; Keer Jin; Wenya Li; Rui Zhang
Journal:  Med Sci Monit       Date:  2018-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.